Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Secondary Health Conditions in Individuals With Multiple Sclerosis: A Cross-Sectional Web-Based Survey Analysis.
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function.
Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.
What is the relevance of quality of life assessment for patients with attention impairment?
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.
MRI pattern in asymptomatic natalizumab-associated PML.
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].
[Clinical features and neuroimaging findings of 12 patients with acute disseminated encephalomyelitis involved in corpus callosum].
Vitamin D deficiency in multiple sclerosis: Should testing and treatment be based on racial background?
Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.
William Austin Sibley, MD (1925-2015).
Immunomodulatory Effect of Chymotrypsin in CNS Is Sex-independent: Evidence of Anti-inflammatory Role for IL-17 in EAE.
Large-scale production of human mesenchymal stem cells for clinical applications.
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.
Deep breathing exercises with positive expiratory pressure in patients with multiple sclerosis - a randomized controlled trial.
Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model.
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
Understanding balance differences in individuals with multiple sclerosis with mild disability: an investigation of differences in sensory feedback on postural control during a Romberg task.
Improved MRI quantification of spinal cord atrophy in multiple sclerosis.
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.
Physiological variation of retinal layer thickness is not caused by hydration: A randomised trial.
Pages
« first
‹ previous
…
409
410
411
412
413
414
415
416
417
…
next ›
last »